Childrens Loratadine Solution
NDC Package 51672-2131-4
Package Information
Childrens Loratadine (loratadine) solution is use only with enclosed dosing cupmL = milliliteradults and children 6 years and over10 mL; do not take more than 10 mL in 24 hourschildren 2 to under 6 years of age5 mL daily; do not take more than 5 mL in 24 hourschildren under 2 years of ageask a doctorconsumers with liver or kidney diseaseask a doctor. This formulation utilizes a solution delivery system. Marketed by Sun Pharmaceutical Industries, Inc., this product is identified by NDC 51672-2131 and is authorized under FDA application ANDA076805.
Identification & Billing
- RxCUI: 692783 - loratadine 5 MG in 5 mL Oral Solution
- RxCUI: 692783 - loratadine 1 MG/ML Oral Solution
- RxCUI: 692783 - loratadine 5 MG per 5 ML Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 51672 - Sun Pharmaceutical Industries, Inc.
- 51672-2131 - Childrens Loratadine
- 51672-2131-4 - 1 BOTTLE in 1 CARTON / 60 mL in 1 BOTTLE
- 51672-2131 - Childrens Loratadine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (51672-2131). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 51672-2131-4 identifies a specific commercial package of 1 bottle in 1 carton / 60 ml in 1 bottle of Childrens Loratadine Sugar Free, a human over the counter drug labeled by Sun Pharmaceutical Industries, Inc.. This solution is formulated for oral use and contains loratadine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sun Pharmaceutical Industries, Inc. on March 17, 2017. The current certification is valid through December 31, 2027.
How is this Sun Pharmaceutical Industries, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 51672213104. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.